Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Clinical Services Laboratory, |
RCV000351516 | SCV000464295 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type VI | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000693341 | SCV000821206 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type VI; Epidermolysis bullosa simplex, autosomal recessive 2 | 2019-11-29 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with valine at codon 812 of the DST protein (p.Ala812Val). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs150656535, ExAC 0.06%). This variant has not been reported in the literature in individuals with DST-related disease. ClinVar contains an entry for this variant (Variation ID: 357601). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV001091113 | SCV001246971 | uncertain significance | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Inherited Neuropathy Consortium | RCV001027479 | SCV001190050 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | research |